Sign In
Buy ANTH
Anthera Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 11.02M and sold 541.51K ANTH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
0 |
| ● Buy | 11.02M shares |
| ● Sell | 541.51K shares |
|
92% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 05, 2018 Buy |
Thompson John Craig President & CEO |
1 847 074 Value: $3.05M |
||
|
Jan 05, 2018 Buy |
Shanahan William R Jr Chief Medical Officer |
567 876 Value: $937.0K |
||
|
Jan 05, 2018 Buy |
Truex Paul F Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Thompson David E. Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Sager Philip Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Mueller Brian Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Furse Brent Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Henney Christopher S Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Henney Christopher S Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Furse Brent Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Mueller Brian Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Sager Philip Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Thompson David E. Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Truex Paul F Director |
84 705 Value: $139.8K |
||
|
Jan 05, 2018 Buy |
Shanahan William R Jr Chief Medical Officer |
567 876 Value: $937.0K |
||
|
Jan 05, 2018 Buy |
Thompson John Craig President & CEO |
1 847 074 Value: $3.05M |
||
|
Oct 24, 2017 Buy |
Pennington James Interim Chief Medical Officer |
4 746 Value: $10K |
||
|
Oct 24, 2017 Buy |
Pennington James Interim Chief Medical Officer |
4 746 Value: $10K |
||
|
Sep 20, 2017 Buy |
Thompson John Craig President & CEO |
8 550 Value: $11.3K |
||
|
Sep 20, 2017 Buy |
Thompson John Craig President & CEO |
8 550 Value: $11.3K |
||
|
Sep 07, 2017 Buy |
Truex Paul F Director |
5 000 Value: $7K |
||
|
Sep 07, 2017 Buy |
Thompson John Craig President & CEO |
10 400 Value: $14.9K |
||
|
Sep 07, 2017 Buy |
Thompson John Craig President & CEO |
10 400 Value: $14.9K |
||
|
Sep 07, 2017 Buy |
Thompson John Craig President & CEO |
10 400 Value: $14.9K |
||
|
Sep 07, 2017 Buy |
Thompson John Craig President & CEO |
10 400 Value: $14.9K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
